IDEX Biometrics ASA (OSL:IDEX)
Norway · Delayed Price · Currency is NOK 9.14
-0.24 (-2.56%)
Jun 4, 2026, 11:44 AM CET
IDEX Biometrics ASA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.25 | 0.84 | 4.14 | 4.09 | 2.84 |
| 0.25 | 0.84 | 4.14 | 4.09 | 2.84 | |
Revenue Growth (YoY) | -69.80% | -79.68% | 1.15% | 44.09% | 159.36% |
Cost of Revenue | 0.61 | 1.68 | 3.91 | 3.24 | 1.25 |
Gross Profit | -0.36 | -0.84 | 0.23 | 0.85 | 1.59 |
Selling, General & Admin | 2.65 | 8.8 | 14.31 | 19.21 | 21.11 |
Research & Development | 1.36 | 2.46 | 2.39 | 3.25 | 2.68 |
Other Operating Expenses | 5.28 | 7.29 | 8.74 | 8.4 | 7.35 |
Operating Expenses | 9.78 | 21.06 | 27.08 | 32.22 | 32.94 |
Operating Income | -10.13 | -21.9 | -26.85 | -31.37 | -31.35 |
Interest Expense | -0.91 | -2.41 | -0.64 | -0.03 | -0.03 |
Interest & Investment Income | 4.12 | 7.91 | 0.84 | 0.1 | 0.01 |
Currency Exchange Gain (Loss) | - | - | - | -1.39 | -1.09 |
Other Non Operating Income (Expenses) | 0 | -0 | -0 | -0 | - |
EBT Excluding Unusual Items | -6.92 | -16.41 | -26.65 | -32.7 | -32.46 |
Legal Settlements | -0.4 | - | - | - | - |
Other Unusual Items | -2.72 | 1.84 | - | - | - |
Pretax Income | -10.04 | -14.57 | -26.65 | -32.7 | -32.46 |
Income Tax Expense | -0.04 | -0.12 | -0.02 | -0.04 | 0.09 |
Net Income | -10 | -14.45 | -26.63 | -32.66 | -32.55 |
Net Income to Common | -10 | -14.45 | -26.63 | -32.66 | -32.55 |
Shares Outstanding (Basic) | 39 | 4 | 3 | 2 | 2 |
Shares Outstanding (Diluted) | 39 | 4 | 3 | 2 | 2 |
Shares Change (YoY) | 842.43% | 63.87% | 23.20% | 11.76% | 19.79% |
EPS (Basic) | -0.26 | -3.48 | -10.52 | -15.90 | -17.71 |
EPS (Diluted) | -0.26 | -3.48 | -10.52 | -16.00 | -17.71 |
Free Cash Flow | -8.62 | -17.53 | -27.25 | -31.64 | -27.67 |
Free Cash Flow Per Share | -0.22 | -4.23 | -10.77 | -15.40 | -15.06 |
Gross Margin | -140.95% | -100.24% | 5.58% | 20.72% | 55.84% |
Operating Margin | -3989.37% | -2604.40% | -648.59% | -766.59% | -1103.87% |
Profit Margin | -3937.80% | -1718.07% | -643.37% | -798.19% | -1146.20% |
Free Cash Flow Margin | -3394.49% | -2084.90% | -658.32% | -773.14% | -974.44% |
EBITDA | -9.65 | -19.39 | -25.82 | -30.45 | -30.37 |
D&A For EBITDA | 0.48 | 2.52 | 1.03 | 0.92 | 0.98 |
EBIT | -10.13 | -21.9 | -26.85 | -31.37 | -31.35 |
Revenue as Reported | 0.25 | 0.84 | 4.14 | 4.09 | 2.84 |